NASDAQ: CARECarter Bankshares Inc Stock
$19.00-0.08 (-0.42%)
Updated Dec 6, 2024
CARE Price
$19.00
Fair Value Price
-$3.15
Market Cap
$438.37M
52 Week Low
$10.95
52 Week High
$20.40
P/E
30.16x
P/B
1.13x
P/S
3.09x
PEG
0.84x
Dividend Yield
N/A
Revenue
$128.51M
Earnings
$14.36M
Gross Margin
100%
Operating Margin
14.24%
Profit Margin
11.2%
Debt to Equity
10.93
Operating Cash Flow
$33M
Beta
1.21
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
CARE Overview
Carter Bankshares, Inc. operates as the bank holding company for Carter Bank & Trust that provides various banking products and services. It accepts various deposit products, including checking, savings, retirement, and money market accounts, as well as longer-term certificates of deposits. The company also offers commercial loans comprising secured and unsecured loans; consumer loans, such as secured and unsecured loans for financing automobiles, home improvements, education, overdraft protection, and personal investments, as well as residential mortgages; real estate construction and acquisition loans; home equity lines of credit; and credit cards, as well as originates and holds fixed and variable rate mortgage loans. In addition, it provides other banking services that include safe deposit boxes, direct deposit of payroll and social security checks, online banking, bill pay, online account opening, mobile deposit, mobile banking, debit cards, e-statements, and ATM services; title insurance and other financial institution-related products and services; and treasury and corporate cash management services. It operates through 69 branches in Virginia and North Carolina. Carter Bankshares, Inc. was founded in 1974 and is headquartered in Martinsville, Virginia.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine CARE's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
C
Value
C
Growth
B
Momentum
C
Sentiment
C
Safety
D
Financials
A
Artificial Intelligence
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Bank
Industry Rating
D
CARE
Ranked#95 of 336
Ranked#95 of 336
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $54.88 | B | |
| $29.09 | B | |
| $39.37 | B |
Be the first to know about important CARE news, forecast changes, insider trades & much more!
CARE News
Overview
Due Diligence Score
–
Industry Average (32)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how CARE scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
CARE ($19.00) is overvalued by 703.11% relative to our estimate of its Fair Value price of -$3.15 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
CARE ($19.00) is not significantly undervalued (703.11%) relative to our estimate of its Fair Value price of -$3.15 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
CARE ($19.00) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 35 more CARE due diligence checks available for Premium users.
Valuation
CARE fair value
Fair Value of CARE stock based on Discounted Cash Flow (DCF)
Price
$19.00
Fair Value
-$3.15
Undervalued by
703.11%
CARE ($19.00) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
CARE ($19.00) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
CARE ($19.00) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
CARE price to earnings (PE)
For valuing profitable companies with steady earnings
Company
30.16x
Industry
37.05x
Market
29.86x
CARE is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
CARE is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
CARE price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
1.13x
Industry
1.18x
CARE is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
CARE price to earnings growth (PEG)
For valuing profitable companies with growth potential
CARE is good value based... subscribe to Premium to read more.
PEG Value Valuation
CARE's financial health
Profit margin
Revenue
$34.5M
Net Income
$5.6M
Profit Margin
16.3%
CARE's Earnings (EBIT) of $18.30M... subscribe to Premium to read more.
Interest Coverage Financials
CARE's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$4.6B
Liabilities
$4.2B
Debt to equity
10.93
CARE's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$10.3M
Investing
-$22.8M
Financing
$55.8M
CARE's operating cash flow ($33.36M)... subscribe to Premium to read more.
Debt Coverage Financials
CARE vs Bank Stocks
Carter Bankshares Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.